NCT00103584View on ClinicalTrials.gov

Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

July 31, 2006

Conditions
Smallpox
Interventions
BIOLOGICAL

LC16m8 Smallpox Vaccine

Trial Locations (4)

40536

University of Kentucky, Kentucky Clinic, Lexington

63110

St. Louis University, Center for Vaccine Development, St Louis

94305

Stanford University, General Clinical Research Center, Stanford

37232-2195

Vanderbilt University Medical Center, General Clinical Research Center, Nashville

Sponsors

Lead Sponsor

VaxGen
All Listed Sponsors
lead

VaxGen

INDUSTRY

NCT00103584 - Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers | Biotech Hunter | Biotech Hunter